NYSE$ZTS

Zoetis · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Reported revenue growth, increased net income, and raised full year revenue guidance.

Zoetis reported a strong start to 2021 with a 22% increase in revenue to $1.9 billion and a 32% increase in net income to $559 million, or $1.17 per diluted share. The company's adjusted net income increased by 33% to $603 million, or $1.26 per diluted share. Due to this strong performance, Zoetis increased its full year 2021 revenue guidance to $7.500 - $7.625 billion and diluted EPS of $4.08 - $4.19 on a reported basis, or $4.42 - $4.51 on an adjusted basis.

  • Revenue reached $1.9 billion, a 22% increase compared to Q1 2020.
  • Net income was $559 million, or $1.17 per diluted share, a 32% increase.
  • Adjusted net income was $603 million, or $1.26 per diluted share, a 33% increase.
  • Full year revenue guidance increased to $7.500 - $7.625 billion.

Headline financials

Total Revenue

$1.87B

Previous: $1.53B+22.0%
EPS (adj)

$1.26

Previous: $0.95+32.6%
Companion Animal Growth

34.0%

Previous: 9.0%+277.8%
Livestock Growth

8.0%

Previous: 1.0%+700.0%
U.S. Revenue Growth

19.0%

Previous: 9.0%+111.1%
International Revenue Growth

25.0%

Previous: 1.0%+2400.0%
Capital Expenditures

-$77M

Previous: -$94M+18.1%
Free Cash Flow

$482M

Previous: $329M+46.5%
Net Income

$559M

Previous: $423M+32.2%
Operating Income

$737M

Previous: $514M+43.4%
Gross Profit

$1.32B

Previous: $1.08B+23.0%
Cash & Equivalents

$3.6B

Previous: $1.95B+84.6%
Total Assets

$13.8B

Previous: $11.5B+19.7%
Stock-Based Comp

$13M

Previous: $16M-18.8%

Revenue & EPS history

Zoetis · Revenue · Quarterly

$1.87B

Q1 2021+22%vs Q1 2020
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Zoetis · $1.87B total across 3 segments · Q1 2021

  • Companion Animal
    $1.08B+35.0%
  • Livestock
    $779M+8.6%
  • Contract Mfg & Human Health
    $16M-20.0%

Forward guidance

Zoetis is increasing its full year 2021 guidance, which includes revenue between $7.500 billion and $7.625 billion, reported diluted EPS between $4.08 and $4.19, and adjusted diluted EPS between $4.42 and $4.51.

Tailwinds

  • Revenue between $7.500 billion and $7.625 billion.
  • Operational growth of 10.5% to 12%.
  • Adjusted cost of sales as a percentage of revenue approximately 30%.
  • Adjusted SG&A expenses between $1.820 billion and $1.870 billion.
  • Adjusted R&D expenses between $500 million and $520 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.4%

Avg return

Earnings day

-0.6%

Avg return

5 days after

+0.5%

Avg return

30 days after

55%

32 / 58 earnings

Positive

+8.1%

Q4 2018

Best reaction

-13.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%-30.9%-28.5%
Q4 2025-2.4%-2.4%-10.1%
Q3 2025-13.7%-16.7%-16.6%
Q2 2025-3.7%-2.9%+0.9%
Q1 2025-5.3%+0.8%+6.7%
Q4 2024-5.1%-10.0%-7.3%
Q3 2024-3.7%-2.8%-3.6%
Q2 2024+5.7%+6.0%+6.7%
Q1 2024+5.4%+6.3%+7.0%
Q4 2023-6.4%-4.2%-11.6%
Q3 2023+7.1%+10.4%+18.3%
Q2 2023+4.8%+5.6%+3.9%
Q1 2023+4.8%+3.7%-3.3%
Q4 2022+7.3%+5.4%+1.9%
Q3 2022-9.3%-7.6%+6.8%
Q2 2022-3.1%-5.9%-12.9%
Q1 2022-4.3%-8.0%-4.4%
Q4 2021-0.7%-2.6%-1.4%
Q3 2021+2.7%+4.3%+5.8%
Q2 2021-1.4%-2.9%+2.4%
Q1 2021-1.3%-2.1%+0.8%
Q4 2020+1.3%-4.0%-8.6%
Q3 2020-2.9%-6.8%-9.4%
Q2 2020+0.7%-0.5%-0.3%
Q1 2020-5.4%-3.7%+7.4%
Q4 2019+0.8%+0.5%-12.2%
Q3 2019-3.0%-3.5%+0.2%
Q2 2019+7.4%+11.1%+13.8%
Q1 2019+1.9%-0.4%-0.7%
Q4 2018+8.1%+7.5%+9.8%
Q3 2018+2.9%+2.9%+4.1%
Q2 2018+6.5%+7.5%+5.3%
Q1 2018-3.6%-1.5%+2.4%
Q4 2017+7.1%+7.9%+13.6%
Q3 2017+6.5%+6.1%+12.1%
Q2 2017-1.6%-3.4%+4.9%
Q1 2017+7.0%+6.9%+12.4%
Q4 2016-4.8%-3.0%-2.1%
Q3 2016+3.6%+5.8%+3.9%
Q2 2016+3.4%+2.2%+3.1%
Q1 2016+0.2%
Q4 2015+3.4%
Q3 2015+5.2%
Q2 2015+0.3%
Q1 2015-0.2%
Q4 2014+4.3%
Q3 2014+4.1%
Q2 2014-2.8%
Q1 2014+0.4%
Q4 2011+0.1%
Q4 2013-3.7%
Q3 2012-0.5%
Q3 2013-2.1%
Q2 2012-1.4%
Q2 2013-0.0%
Q1 2012+0.9%
Q4 2012+0.9%
Q1 2013+2.2%
Q3 2011
Q2 2011
Q1 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro